Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide
- 1 November 2003
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 49 (5) , 826-831
- https://doi.org/10.1016/s0190-9622(03)02099-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and AustraliaNew England Journal of Medicine, 2003
- Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South AmericaNew England Journal of Medicine, 2003
- Interstitial Granulomatous Drug Reaction with a Histological Pattern of Interstitial Granulomatous DermatitisThe American Journal of Dermatopathology, 2001
- Panniculitis. Part I. Mostly septal panniculitisJournal of the American Academy of Dermatology, 2001
- Wells’ syndrome and human immunodeficiency virus infectionBritish Journal of Dermatology, 2000
- Cutaneous reactions at the site of post-infection gp160 vaccination therapy in HIV-1+ patientsInternational Journal of Dermatology, 1998
- Interferon Alfa Treatment of a Patient with Eosinophilic Cellulitis and HIV InfectionNew England Journal of Medicine, 1997
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- Granuloma annulare in patients with human immunodeficiency virus infectionsJournal of the American Academy of Dermatology, 1989
- Eosinophilic cellulitisBritish Journal of Dermatology, 1979